Skip to main content
Realcan Pharmaceutical Group Co.,Ltd. logo

Realcan Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 002589 ISIN · CNE1000013X5 LEI · 300300YI5IV3FBRRSJ48 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,678 across all filing types
Latest filing 2022-01-23 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002589

About Realcan Pharmaceutical Group Co.,Ltd.

https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. specializes in the distribution of pharmaceutical products, medical devices, and healthcare consumables. The company operates an extensive supply chain network, providing integrated logistics and distribution services primarily to medical institutions and healthcare providers. Its core operations include the procurement, storage, and delivery of a wide range of medical supplies, supported by advanced information management systems and cold-chain logistics capabilities. Realcan also offers value-added services such as hospital supply chain optimization, third-party logistics, and financial solutions tailored to the healthcare industry. By focusing on a direct-to-hospital distribution model, the company aims to enhance the efficiency of medical supply procurement and ensure the timely delivery of critical healthcare products.

Recent filings

Filing Released Lang Actions
瑞康医药独立董事对第四届董事会第十八次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters discussed at the 18th meeting of the 4th board of directors of 瑞康医药集团股份有限公司. It includes approval of the appointment of the 2021 audit firm and a proposal regarding the use of idle funds to purchase financial products. The document references compliance with Shenzhen Stock Exchange listing rules and company bylaws. It is a formal opinion letter from independent directors rather than a full audit report or annual report. The content aligns with Board/Management Information (MANG) as it relates to board meeting decisions and approvals, not a standalone audit report or financial report. The document length is short and focused on board opinions and approvals, consistent with MANG filings.
2022-01-23 Chinese
关于召开2022年第一次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about convening the 2022 first extraordinary general meeting (临时股东大会) of 瑞康医药集团股份有限公司. It includes information about the meeting time, location, voting procedures (both onsite and online), eligibility, agenda items (such as the proposal to renew the accounting firm), and proxy authorization forms. There is no financial data or report content, but rather an announcement and instructions related to the shareholders meeting. The document length is about 4008 characters, which is relatively short and consistent with a meeting notice rather than a full report. This fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or other shareholder meetings. Therefore, the document is best classified as AGM Information (AGM-R).
2022-01-23 Chinese
关于续聘会计师事务所的公告
Regulatory Filings Classification · 90% confidence The document is an announcement regarding the reappointment of an accounting firm (auditor) for the company 瑞康医药集团股份有限公司 for the 2021 fiscal year. It details the qualifications, independence, and audit fees of the accounting firm 天圆全会计师事务所, and mentions that the reappointment is subject to approval at the 2022 first extraordinary shareholders meeting. The document does not contain actual financial statements or audit results but is a formal announcement about the auditor appointment process and related governance procedures. The document length is 3154 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document fits best under the category of Audit Report / Information (AR) as it relates to audit firm appointment and audit-related disclosures but is not a full annual report or audit report itself. However, since it is primarily an announcement about auditor reappointment and not the audit report or financial statements, it is more appropriate to classify it as Regulatory Filings (RNS) because it does not contain substantive audit results or financial data but is a regulatory disclosure about audit firm appointment.
2022-01-23 Chinese
关于全资子公司为上市公司提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from 瑞康医药集团股份有限公司 regarding guarantees provided by its wholly-owned subsidiaries to the listed company. It details the guarantee amounts, involved banks, internal approvals, and financial data of the company. The document is a formal disclosure about a financing-related guarantee arrangement, not a full financial report or earnings release. It does not contain comprehensive financial statements or detailed management discussion but focuses on a specific capital/financing update related to credit facilities and guarantees. The document length is 2592 characters, which is relatively short and typical for an announcement rather than a full report. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2022-01-23 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by 瑞康医药集团股份有限公司. It discusses the unusual price movements of the company's stock over several days, the company's investigation into the cause, confirmation that no undisclosed material information exists, and a risk warning to investors. There are no financial statements, no detailed financial data, no management discussion of results, nor is this a report or presentation. The document is a regulatory announcement related to stock price behavior and compliance with stock exchange rules. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2022-01-13 Chinese
关于实际控制人部分股份解除质押的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the release of pledged shares by the actual controller of the company, including details about the number of shares released from pledge, pledge start dates, and the status of pledged shares. It does not contain financial statements, earnings data, or management discussion. It is a regulatory announcement about share pledge status and related shareholder information. The document length is short (1392 characters), and it is not a report or presentation but a specific shareholder-related disclosure. This fits best under the category of Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2022-01-10 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.